89 related articles for article (PubMed ID: 15330156)
1. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
Sesterhenn AM; Mandic R; Dünne AA; Werner JA
Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
[TBL] [Abstract][Full Text] [Related]
4. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell nicotinic acetylcholine receptor expression in head and neck squamous cell carcinoma pathogenesis.
Carracedo DG; Rodrigo JP; Nieto CS; Gonzalez MV
Anticancer Res; 2007; 27(2):835-9. PubMed ID: 17465209
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.
Kondoh N; Schweinfest CW; Henderson KW; Papas TS
Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells.
Beier UH; Maune S; Meyer JE; Görögh T
Anticancer Res; 2006; 26(3A):1941-6. PubMed ID: 16827128
[TBL] [Abstract][Full Text] [Related]
13. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
[TBL] [Abstract][Full Text] [Related]
14. Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.
Rivera RS; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Pehlivan D; Yamanaka N; Shimizu K; Nagai N
Oncol Rep; 2008 May; 19(5):1079-84. PubMed ID: 18425361
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
16. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report.
Lee KD; Lee HH; Joo HB; Lee HS; Yu TH; Chang HK; Jeon CH; Park JW
Anticancer Res; 2006; 26(2B):1513-8. PubMed ID: 16619566
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
18. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
20. RT-PCR expression profiling of matrix metalloproteinases and their specific inhibitors in cell lines and fresh biopsies of squamous cell carcinomas of the head and neck.
Dünne AA; Mandic R; Falkenberg S; Dalchow CV; Sesterhenn AM; Werner JA
In Vivo; 2005; 19(5):943-8. PubMed ID: 16097450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]